Sociogeographical factors associated with participation in colorectal cancer screening;Analyse socioterritoriale des facteurs associés à la participation au dépistage organisé du cancer colorectal.

Gastroenterologie Clinique et Biologique

Volumn 34, Issue 10, 2010, Pages 534-540

  Le Retraite, L ^a   Eisinger, F ^b   Loundou, A ^c   Rinaldi, Y ^c   Seitz, J F ^d   Auquier, P ^c  

^a Association Arcades   (France)

^b AIX MARSEILLE UNIV   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d TIMONE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; FEMALE; FRANCE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MIGRATION; PATIENT PARTICIPATION; SEX DIFFERENCE; SOCIAL ASPECT;

AGED; ANALYSIS OF VARIANCE; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FRANCE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SOCIOECONOMIC FACTORS; URBAN POPULATION;

EID: 78049284354     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2010.06.007     Document Type: Article

References (32)

1. Serra D, Goulard H, Duport N, Bloch J. Pratique du test de détection de sang occulte dans les selles (Hémoccult®) dans la population française. Enquête décennale santé Insee, France 2002-2003. BEH no 1; 1er janvier
2. Institut national du cancer. Le cancer colorectal. Téléchargeable sur le site: http://www.e-cancer.fr/.
3. Kronborg O., Fenger C., Olsen J., Jorgensen O.D., Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996, 348:1467-1471.
4. Hardcastle J.D., Chamberlain J.O., Robinson M.H., Moss S.M., Amar S.S., Balfour T.W., et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348:1472-1477.
5. Faivre J., Dancourt V., Lejeune C., Tazi M.A., Lamour J., Gerard D., et al. Reduction in colorectal cancer mortality by faecal occult blood screening in a French controlled study. Gastroenterology 2004, 126.
6. Consensus Conference: prevention screening and management of the colonic cancers. Paris, France, January 29-30, 1998. Proceedings. Gastroenterol Clin Biol 1998;22(3 Suppl.):S1-S295.
7. Farrands P.A., Harcastle J.D., Chamberlin J., Moss S. Factors affected compliance with screening for colorectal cancer. Community Med 1984, 6(1):12-19.
8. Lindholm E., Berglund B., Haglind E., Kewenter J. Factors associated with participation in screening for colorectal cancer with faecal occult blood testing. Scand J Gastroenterol 1995, 30:171-176.
9. Weller D.P., Owen N., Hiller J.E., Wilson K., Wilson D. Colorectal cancer and its prevention: prevalence of beliefs, attitudes, intentions and behaviour. Aust J Public Health 1995, 19:19-23.
10. Madlensky L., Esplen M.J., Gallinger S., McLaughlion J.R., Goel V. Relatives of colorectal cancer patients. Factors associated with screening behaviour. Am J Prev Med 2003, 25:187-194.
11. Ramji F., Cotterchio M., Manno M., Rabeneck L., Gallinger S. Association between subject factors and colorectal cancer screening participation in Ontario, Canada. Cancer Detect Prev 2005, 29(3):221-226.
12. Eisinger F., Cals L., Calazel-Benque A., Blay J.Y., Coscas Y., Dolbeault S., et al. Impact of organised programs on colorectal cancer screening. BMC Cancer 2008, 8:104.
13. Duport N., Ancelle-Park R. Do sociodemographic factors influence mammography use of French women? Analysis of a French cross-sectional survey. Eur J Cancer Prev 2006, 15:219-224.
14. Robert S.A., Strombom I., Trentham-Dietz A., Hampton J.M., McElroy J.A., Newcom P.A., et al. Socioeconomic risk factors for breast cancer. Epidemiology 2004, 15:442-450.
15. Zackrisson S., Lindström M., Moghaddassi M., Andersson I., Janzon L. Social predictors of non-attendance in an urban mammographic screening program: a multilevel analysis. Scand J Public Health 2007, 35:548-554.
16. Matson S., Andersson I., Berglund G., Janzon L., Manjer J. Nonattendance in mammographic screening: a study of intraurban differences in Malmö, Sweden, 1990-1994. Cancer Detect Prev 2001, 25:132-137.
17. Zackrisson S., Andersson I., Manjer J., Janzon L. Non-attendance in breast cancer screening is associated with unfavourable socioeconomic circumstances and advanced carcinoma. Int J Cancer 2004, 108:754-760.
18. Langevin P, Juan JC. Marseille, une métropole entre Europe et Méditerranée. La documentation française, Paris, 2007.
19. URCAM. Les disparités de consommation de soins de ville dans les 16 arrondissements de Marseille. Actes de la réunion d'échanges du 28 mai 2002.
20. Groupe technique national sur le dépistage du cancer colorectal. Cahier des charges pour l'organisation d'un programme de dépistage du cancer colorectal, 2001.
21. Kalff A.C., Kroes M., Vles J.S.H., Hendriksen J.G.M., Feron F.J.M., Steyaert J., et al. Neighbourhood level and individual level SES effects on child problem behaviour: a multilevel analysis. J Epidemiol Community Health 2001, 55:246-250.
22. Marinacci C., Spadea T., Biggeri A., Demaria M., Caiazzo A., Costa G. The role of individual and contextual socioeconomic circumstances on mortality: analysis of time variations in a city of north west Italy. J Epidemiol Community Health 2004, 58:199-207.
23. Goulard H, Ancelle-Park R, Julien M, Bloch J. Le cancer colorectal en France: évaluation 2002 à 2004. http://www.invs.sante.fr/publications/2004/cancer_colorectal/pdf%202006.
24. Launoy G., Herbert C., Vallée J.P., Desoubeaux N., Réaud J., Ollivier V. Le dépistage de masse du cancer colorectal en France. Expérience auprès de 165000 personnes dans le Calvados. Gastroenterol Clin Biol 1996, 20:228-236.
25. Slattery M.L., Kinney A.Y., Levin T.R. Factors associated with colorectal cancer screening in a population-based study: the impact of gender, health care source, and time. Prev Med 2004, 38:276-283.
26. Shapiro J.A., Seef L.C., Nadel M.R. Colorectal cancer screening: tests and associated health behaviour. Am J Prev Med 2001, 21:132-137.
27. Weitzman E.R., Zapka J., Estabrook B., Goins K.V. Risk and reluctance: understanding impediments to colorectal cancer screening. Prev Med 2001, 32:502-513.
28. Tazi M.A., Faivre J., Dassonville F., Lamour J., Milan C., Durand G. Participation in faecal occult blood screening for colorectal cancer in a well defined French population: results of five screening rounds from 1988 to 1996. J Med Screen 1997, 4:147-151.
29. Lees K.A., Wortley P.M., Coughlin S.S. Comparison of racial/ethnic disparities in adult immunization and cancer screening. Am J Prev Med 2005, 29:404-411.
30. De Alba I., Ngo-Metzger Q., Sweningson J.M., Hubbel F. Pap smear use in California: are closing the racial/ethnic gap?. Prev Med 2005, 40:747-755.
31. Coughlin S.S., Uhler R.J. Breast and cervical cancer screening practices among Hispanic women in the United States and Puerto Rico, 1998-1999. Prev Med 2002, 34:242-251.
32. Selvin E., Brett K.M. Breast and cervical cancer screening: sociodemographic predictors among white, black, and Hispanic women. Am J Public Health 2003, 93:618-623.